Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Intuitive Surgical/IBM

This article was originally published in The Gray Sheet

Executive Summary

Companies jointly file suit against Computer Motion, Inc. in Wilmington, Delaware federal court, Intuitive announces April 4. Complaint alleges that CMI willfully infringed U.S. Patent No. 6,201,984 in developing the Aesop, Zeus and Hermes voice-controlled products. Issued to IBM on March 13, the '984 patent is exclusively licensed to Intuitive for use with the company's da Vinci surgical system and EndoWrist instruments, Intuitive says

You may also be interested in...



Intuitive Surgical/IBM v. Computer Motion Set For Aug. 12 Jury Trial

Intuitive Surgical and IBM's joint litigation against Computer Motion for patent infringement covering voice-controlled robotic surgical devices is set to begin Aug. 12 in Wilmington, Delaware federal court

Intuitive Surgical/IBM v. Computer Motion Set For Aug. 12 Jury Trial

Intuitive Surgical and IBM's joint litigation against Computer Motion for patent infringement covering voice-controlled robotic surgical devices is set to begin Aug. 12 in Wilmington, Delaware federal court

Intuitive Da Vinci Robotic Device To Enter Heart Surgery Market By Year End

Intuitive Surgical expects to gain 510(k) clearance for expanded use of its da Vinci robotic surgical system for mitral valve repair and atrial septal defect closure by year-end

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel